The Effectiveness of Cognitive Behavioral Therapy on Emotion Self-regulation and its Components in Patients with Schizophrenia: A Semi-experimental Study

authors:

avatar Hanieh Nobakht ORCID 1 , * , avatar Mehrdad Mazaheri Dasht Arjandi ORCID 2 , avatar Fatemeh Soghra Karbalaei Herafteh ORCID 1

Department of Psychology, Zahedan Branch, Islamic Azad University, Zahedan, Iran
Department of Psychology, Faculty of Educational Sciences and Psychology, University of Sistan and Baluchestan, Zahedan, Iran

how to cite: Nobakht H, Dasht Arjandi M M, Karbalaei Herafteh F S. The Effectiveness of Cognitive Behavioral Therapy on Emotion Self-regulation and its Components in Patients with Schizophrenia: A Semi-experimental Study. Jundishapur J Chronic Dis Care. 2023;12(2):e135134. https://doi.org/10.5812/jjcdc-135134.

Abstract

Background:

Cognitive-behavioral therapy (CBT) has always been used as an effective method to improve emotion regulation and train patients to reduce mental disorders. Therefore, the current research has investigated the effectiveness of CBT on emotion self-regulation and its components in patients with schizophrenia.

Methods:

This research was a semi-experimental study with an experimental group and a control group. The statistical population of this study included all patients with schizophrenia in Hayat Rehabilitation and Treatment Center for Chronic Mental Patients in 2021 - 2022. Among the above study population, a total of 30 people (n = 15 per group) with confirmed schizophrenia were selected and studied using the convenience sampling method. The experimental group received CBT for eight 60-minute sessions, but the control group received no training. Both groups completed the Self-regulation Inventory (SRI-25) at the pre-test and post-test stages. The data of this study were analyzed by multivariate analysis of variance (MANOVA) using SPSS software version 16.

Results:

Data analysis showed that after 8 sessions of CBT in the experimental group, the mean scores of emotion regulation and its sub-components significantly increased in the experimental group than in the control group (0.05).

Conclusions:

Therefore, considering the effectiveness of CBT in improving the emotion self-regulation dimensions, it is advisable to use this training to improve emotion self-regulation in patients with schizophrenia.

1. Background

Schizophrenia, as a severe mental illness, leads to impaired reality evaluation, emotion dysregulation, impaired thinking, impaired decision-making, and severe communication problems (1). Schizophrenia, or psychosis, is a severe and extremely destructive clinical syndrome affecting cognition, emotion, perception, and other behavioral aspects. Schizophrenia usually starts before age 25 and persists lifelong in some cases, and may affect individuals belonging to any social class (2). Schizophrenia is one of the most debilitating psychotic disorders. In addition, schizophrenia and severe mental illnesses are increasingly considered neurological disorders (3). It has been reported in most studies that the cognitive impairment that starts from the first period of schizophrenia continues at least until middle age (4, 5). Also, the prevalence of schizophrenia is approximately one percent (6), and 5 - 25% of individuals with this disorder are treated annually. Moreover, its prevalence is equal in men and women, but the disease onset is earlier in men (7).

Emotional intelligence is also another construct that plays a fundamental role in various disorders (8). Emotional intelligence is a type of non-cognitive intelligence that includes cognition, emotions, appropriate decision-making, the ability to manage one's mood appropriately, impulse control, and desirable social skills (9). One of the main components of emotional intelligence is the emotion regulation process. There are several definitions of emotion regulation. Emotion regulation specifically describes how individuals experience, organize, or regulate emotions, which increases their tolerance in situations of helplessness and helps manage or regulate emotions, including awareness, acceptance, and understanding of emotions to control impulsive behaviors (10). Emotion regulation refers to a wide range of biological, social, and behavioral processes (11). It is also a process in which emotions automatically or voluntarily monitor, evaluate, and modify emotional reactions to pain (12). Many studies have been conducted on the role of emotion regulation or emotion dysregulation due to various disorders, particularly schizophrenia (13). The Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition (DSM-5) also introduces a defect or disorder in emotion regulation, along with a disorder in cognition or behavior, as one of the essential elements in the definition of a mental disorder (14). It is believed that there is a wide range of deficits and problems of emotion regulation in schizophrenia (15), and emotion regulation in schizophrenia may initiate a new insight into this disorder, in which mood instability may be a prominent feature, possibly forming schizophrenia (16).

Today, there is no doubt about the use of psychological treatments in the treatment of schizophrenia because drug therapy, which is considered the first-line treatment in schizophrenia, has some limitations. However, despite the use of medicine, the high rate of relapse continues. In addition, a large number of patients still suffer from persistent positive symptoms, and common antipsychotic drugs have limited effects on negative symptoms and impaired cognitive functions and social functioning (17). Therefore, due to the limitations of drug therapy, much attention has been paid to the treatment of schizophrenia in the field of psychology, and a variety of treatments have been proposed to deal with this disorder effectively; however, what should be noted is the difference between these interventions in terms of ease of implementation and continuity of treatment outcomes. In this regard, researchers have shown that cognitive-behavioral therapy (CBT) significantly affects the improvement of schizophrenia (18).

CBT is a combination of cognitive behavioral approaches, helping the patient to recognize his/her distorted and ineffective thinking patterns through Socratic discussions and organized behavioral assignments. The emphasis is mainly on the behavioral dimension in some aspects of the treatment and the cognitive dimension in other aspects (19). In fact, it can be stated that the quality of life improves when CBT is used. Godfrin & van Heeringen, as well as Driessen & Hollon, have concluded that this intervention affects all aspects of an individual’s life and significantly affects an individual’s increased satisfaction with his/her life (20, 21). There is also strong evidence that the combination of drug therapy and CBT leads to reduced relapse and a longer recovery duration in psychotic patients compared to drug therapy alone (22). Recent studies have shown that CBT has been effective in preventing relapse in patients with schizophrenia (23). A study on the effectiveness of CBT on positive symptoms of schizophrenia showed that CBT increased positive symptoms in individuals with schizophrenia (24).

Considering that schizophrenia is one of the most destructive psychiatric disorders, and according to the literature review, few studies have been conducted on the effectiveness of CBT on emotional self-regulation in these patients; therefore, the present study seems important, contributing to more knowledge in disease pathology. Also, given that emotional intelligence and emotional self-regulation play an important role in behaviors and social relationships, such research can be effective and helpful in clinical and treatment centers.

2. Objectives

The current study aims to answer the following basic question: Is CBT effective on emotion self-regulation and its components in patients with schizophrenia?

3. Methods

3.1. Design

The current research is a semi-experimental study with a pretest-posttest design and a control group.

3.2. Samples

The study population includes all patients with schizophrenia who were admitted to Hayat Rehabilitation and Treatment Center for Chronic Mental Patients in 2021 - 2022.

The sample size of the present study was determined by referring to Cohen's table to specify the sample size in experimental studies and taking into account the effect size of 0.70, the test power was 0.91, the significance level was 0.05, and the minimum sample size for each group was 15 people. In addition to Cohen's formula, according to Gall et al., translated by Nasr, the criterion for selecting 15 people for each group is also based on previous studies and experts' opinions, so in semi-experimental studies, a 15-people sample size is considered sufficient (25). Accordingly, 30 people were selected and randomly assigned to experimental and control groups using the convenience sampling method (n = 15 per group). The Self-regulation Inventory (SRI-25) was completed by both groups in the pre-test phase, and the experimental group then received CBT for eight 60-minute sessions per week. Finally, the SRI-25 was completed by both groups in the post-test phase.

The objectives of the study were explained to all participants. All ethical principles were observed, including signing a voluntary informed consent, the right to withdraw from the study at any stage, non-disclosure of information, the confidentiality of all data, and avoiding harm to participants. The research protocol was approved by the Research Ethics Committee of Islamic Azad University (code: IR.IAU.ZAH.REC.1401.067).

The research inclusion criteria included being able to read and write, having a brain injury, having dementia, having a special neurological disease that needs special care, not receiving electroshock at least six months before the study, and finding no shock during the treatment The exclusion criteria were being illiterate, having no brain injury, having no dementia, and having no special neurological disease that needs special care. The patient should not have been seriously affected by the side effects of antipsychotic drugs in such a way that he/she was required to receive special treatment except for the usual treatments. If the patient received an electroshock for any reason during the treatment, he/she would be excluded from the study; also, the patient should not have received psychological treatment, such as metacognitive therapy, music therapy, or family therapy.

3.3. Intervention

The content and goals of the sessions were taken and expanded from the “Cognitive-Behavioral Therapy of Schizophrenia” book by Kingdon and Turkington (26). The training sessions aimed to improve emotion regulation through question-answer and group discussion. The summary of the meetings is presented in Table 1.

Table 1.

Summary of the Cognitive-behavioral Therapy Sessions Based on the Protocol of Kingdon and Turkington (2004)

SessionContent and Activities of Each Session
First sessionEstablishing a therapeutic relationship and familiarizing the patient with CBT and group rules
Second sessionTeaching conversation and negotiation skills
Third sessionTeaching problem-solving skills
Fourth sessionAnger and aggression control training
Fifth sessionTeaching relaxation techniques
Sixth sessionStress management skills training
Seventh sessionIdentifying negative thoughts, logical responses to negative thoughts, and correcting them
Eighth sessionA review of previous sessions and answer the questions

3.4. Instruments

3.4.1. The Self-regulation Inventory

The Self-regulation Inventory (SRI-25) created by Ibanez et al. contains 25 questions and five subscales (positive functioning, controllability, disclosure of feelings and needs, assertiveness, and well-being seeking) and is scored on a five-point Likert scale from 1 to 5. Psychometric properties of the scale have been approved in foreign (27, 28) and domestic (29) preliminary studies. For the 72-question version, Cronbach's alpha coefficient is 0.74 - 0.92. (30), and for the 25-item version, it is 0.68 - 0.84 (28), confirming the scale’s internal consistency. The one-month test-retest reliability of the SRI-25 has been reported to be 0.87 (30). Examining the psychometric properties of the Persian version of the questionnaire in a sample of 676 students, Cronbach's alpha of each subscale was 0.90 - 0.97, indicating good internal consistency of the test. The correlation coefficients of 134 people from the above-mentioned sample size were calculated twice with a four-six-week interval to measure test-retest reliability. The correlation coefficient for the total scores of self-regulation (r = 0.875), positive performance (r = 0.82), controllability (r = 0.71), disclosure of feelings and needs (r = 0.78), assertiveness (r = 0.80), and well-being seeking (r = 0.86) were significant at a P < 0.001 level. Also, these coefficients confirmed the scale’s retest reliability (31).

3.5. Statistical Analysis

The data obtained from the present study were analyzed using descriptive statistics (mean and standard deviation (SD)) and inclusive inferential statistics (multivariate analysis of covariance (MANCOVA)) using SPSS software version 16.

First, assumptions of the MANCOVA test, including the normality of the data distribution, the variance homogeneity, and the slope of the regression line, were investigated.

4. Results

The analysis of the covariance (ANCOVA) test was used to answer the question of whether CBT has a significant effect on emotion self-regulation and its components (positive actions, controllability, expression of feelings and needs, assertiveness, and well-being seeking) in patients with schizophrenia. Furthermore, the Kolmogorov-Smirnov test was used to determine the normality of the data related to positive actions in the pre-test (K-S = 1.06, P ≥ 0.20) and post-test (K-S = 0.62, P ≥ 0.83), controllability in the pre-test (K-S = 0.17, P ≥ 0.12) and post-test (K-S = 0.82, P ≥ 0.50), expression of feelings and needs in the pre-test (K-S = 1.10, P ≥ 0.17) and post-test (K-S = 0.91, P ≥ 0.37), assertiveness in the pre-test (K-S = 0/68, P ≥ 0.74) and post-test (K-S = 0.71, P ≥ 0.68), well-being seeking in the pre-test (K-S = 0.43, P ≥ 0.99) and post-test (K-S = 0.74, P ≥ 0.63), and emotion regulation in the pre-test (K-S = 0/71, P ≥ 0.69) and post-test (K-S = 1.25, P ≥ 0.08). The results showed a significant difference (0.05), and all the components of emotion regulation were normally distributed (Table 2).

Table 2.

Mean ± Standard Deviation of Emotion Regulation and Its Dimensions in Experimental and Control Groups at the Pre-test and Post-test Stages

Variables and PhaseInterventionControlP-Value
Positive actions
Pre-test15.53 ± 3.6220.33 ± 12.20< 0.05
Post-test25.73 ± 3.634.38 ± 4.02< 0.05
Controllability
Pre-test14.53 ± 1.9521.73 ± 3.36< 0.05
Post-test24.26 ± 2.6512.13 ± 2.58< 0.05
Expression of feelings and needs
Pre-test15.86 ± 4.7321.86 ± 2.85< 0.05
Post-test26.26 ± 3.7313.80 ± 3.05< 0.05
Assertiveness
Pre-test16.46 ± 4.1519.73 ± 2.93< 0.05
Post-test26.46 ± 4.8211.80 ± 3.72< 0.05
Well-being seeking
Pre-test11.46 ± 2.7919.33 ± 3.71< 0.05
Post-test19.66 ± 2.4610.86 ± 2.79< 0.05
Emotion regulation
Pre-test73.86 ± 7.20103.00 ± 8.19< 0.05
Post-test122.40 ± 7.4260.80 ± 7.94< 0.05

As Table 3 shows, the assumption of variance homogeneity was confirmed since there was no statistically significant difference between the studied variables.

Table 3.

The Test of Variance Homogeneity Results

Tests of Variance HomogeneityFDF1DF2P-Value
Research variables0.631280.43
Positive actions0.081280.77
Controllability1.101280.30
Expression of feelings and needs0.411280.52
Assertiveness 0.101280.74
Well-being seeking 0.141280.70

Another assumption of ANCOVA is the regression line slope. The results of different dimensions were as follows: Positive actions (f = 0.85, P = 0.54), controllability (f = 0.06, P = 0.79), expression of feelings and needs (f = 0.20, P = 0.89), assertiveness (f = 0.38, P = 0.86), well-being seeking (f = 1.36, P = 0.29), and the total score of emotion regulation at the pre-test and post-test stages (f = 1.26, P = 0.38). The results of the homogeneity of the slope of the regression line showed that the data supported the slope of the regression hypothesis due to the significance level of P < 0.05. Due to the confirmation of the three conditions, we can now take the MANCOVA.

The results of the Wilks's lambda test, comparing the cognitive behavioral therapy training intervention group with the control group in terms of a new variable obtained from the linear combination of dependent variables, indicate a significant difference overall (Wilks' lambda = 0.07, f = 49.31, P < 0.05). The results demonstrate a significant difference between the intervention group and the control group based on the dependent variables, with this difference accounting for 62% of the variance. In other words, 62% of the variance can be attributed to the differing influence of the dependent variables between the experimental and control groups. To further explore which specific dependent variables show a significant difference between the two groups, univariate covariance analysis was conducted using the MANKOVA test, and the results are presented in Table 4.

Table 4.

Multivariate Analysis of Covariance (in the Analysis of Covariance Context) to Investigate the Effect of Cognitive-behavioral Therapy on the Variable of Emotion Self-regulation and Its Components

VariablesSum of SquaresDegrees of FreedomMean SquareFSignificance LevelEffect Size
Positive actions366.951366.9568.470.050.74
Controllability346.851346.8561.860.050.72
Expressing feelings and needs398.761398.7650.880.050.68
Assertiveness 546.401546.4058.710.050.71
Well-being seeking 251.691251.6962.620.050.73

In order to test the hypotheses more precisely, the results of MANCOVA for each of the CBTs are given below.

After removing the pre-test effect on the dependent variables, the results of Table 4 show a significant difference between the adjusted mean scores of positive actions (f = 68.47, η2 = 0.74, P < 0.05), controllability (f = 61.86, η2 = 0.72, P < 0.05), expression of feelings and needs (f =50.88, P < 0.05, η2 = 0.68), assertiveness (η2 = 0.71, P < 0.05, f = 58.71), and well-being seeking (η2 = 0.73, P < 0.05, f = 62.62) at the pre-test and post-test stages. According to the eta coefficients, CBT was the most effective on the positive actions variable (0.74%); that is, 0.74% of the difference in the follow-up scores of the positive actions variable is related to the CBT effect.

5. Discussion

The present study aimed to determine the effectiveness of CBT on emotion self-regulation and its components in patients with schizophrenia. The results of the current research showed that CBT improved emotion self-regulation and its components in patients with schizophrenia in the post-test stage (Table 4), which are consistent with some previous studies (13, 32, 33).

The literature review shows no similar research published on the effectiveness of CBT on clinical symptoms of schizophrenia. Therefore, the current research is considered an innovation and initiative in using CBT to reduce clinical symptoms and fear of negative evaluation of patients with schizophrenia. For this reason, the results of the current research are compared with the results of studies on similar variables and finally explained.

The results of previous studies have shown that CBT reduces the patients’ negative and increases positive symptoms, leading to improving the patients’ cognitive and behavioral performance, while in the control group, no change was observed in any of the scales at the three evaluation stages. The cause of schizophrenia requires a comprehensive treatment plan. Cognitive-behavioral therapy, which is based on sociocultural principles and conditions, can play an effective role in improving cognitive and behavioral performance and reducing disease symptoms (32). Schizophrenia causes a decline and defects in the emotion regulation process in those suffering from this disorder (13). For this reason, the use of some adaptive emotion regulation strategies, such as cognitive re-evaluation in facing anxiety and reducing negative emotions, can increase positive emotions in many cases (34). The emotion regulation ability can be acquired and learned through training and practice. Therefore, CBT effectiveness can be explained by the processes governing it (35). This treatment specifies values and committed actions, and the use of adaptive emotion regulation strategies under stressful situations and negative emotions is an important factor in improving physical and mental health. Therefore, maladaptive emotion regulation strategies lead to increased anxiety and depression (36). However, adaptive regulation strategies, such as acceptance, refocusing on planning, and putting into perspective, will positively affect the individual's social performance and lead to the cognitive reconstruction of the problem and, consequently, improved mental health status. CBT challenges negative thoughts, such as self-blame, and replaces logical thoughts, including positive re-evaluation, and individuals are asked to emphasize, practice, and deepen it.

Therefore, CBT can have a significant effect on improving cognitive emotion regulation (37). Patel et al. showed in their study that CBT was more effective than drug therapy in reducing the severity of schizophrenia symptoms (38). Wykes et al. also found in their study that cognitive rehabilitation therapy effectively improved the cognitive and social functions of individuals with schizophrenia (39). The findings of Sheybani et al. indicated that CBT significantly reduced the negative components of emotion self-regulation, i.e., blaming others, rumination, and catastrophizing, and increased the positive components of emotional regulation, namely, positive attention, positive evaluation, and attention. CBT also was shown to cause the irritability of the sample group to decrease significantly, so it can be concluded that this treatment method can be effective in regulating emotions and reducing the irritability of these patients (40).

5.1. Conclusions

Inhibition and suppression of emotions are among the main causes of pain and various diseases (33), causing psychological distress, so individuals with mental disorders are forced to suppress them due to the reduced ability to identify emotions, thereby increasing subsequent distress, which itself leads to a vicious circle in the patient and his/her attitude toward treatment and disease. It can also be stated that the ability to control psychological pressure in patients with schizophrenia is damaged due to failure to meet their own and others' needs, the feeling of lack of control over life, and excessive distress; therefore, they suppress their emotions more frequently. Finally, it can be stated that CBTs have always been used and effective in treatment, reduction of symptoms, and improvement of emotions and cognitive emotion regulation. In this regard, the results of the present study showed that CBT directly challenged negative thoughts, which could be more effective in using adaptive cognitive emotion regulation strategies.

5.2. Limitations and Suggestions

Some of the limitations of the current research include the self-reporting of the research tool and the lack of a follow-up period. For this reason, and considering that the current research was conducted in a care center for chronic mental patients in the city of Zahedan, it is suggested that the long-term effects of CBT be examined with a follow-up period in future studies. This research should be conducted in other centers, particularly in government hospitals, in the form of a broader demographic study with a larger sample size. Therefore, it is suggested that CBT be taught in counseling centers to reduce the problems of patients with schizophrenia and improve emotional self-regulation.

Acknowledgements

References

  • 1.

    Schizophrenia. American Psychology Assocation; 2012. Available from: https://www.apa.org/topics/schizophrenia.

  • 2.

    Kaplan HI, Sadock BJ. Synopsis of psychiatry: Behavioral sciences clinical psychiatry. 5th ed. Williams & Wilkins Co; 1988. 725 p.

  • 3.

    Hill SK, Bjorkquist O, Carrathers T, Roseberry JE, Hochberger WC, Bishop JR. Sequential processing deficits in schizophrenia: relationship to neuropsychology and genetics. Schizophr Res. 2013;151(1-3):91-6. [PubMed ID: 24119464]. [PubMed Central ID: PMC4479132]. https://doi.org/10.1016/j.schres.2013.09.012.

  • 4.

    Schaefer J, Giangrande E, Weinberger DR, Dickinson D. The global cognitive impairment in schizophrenia: consistent over decades and around the world. Schizophr Res. 2013;150(1):42-50. [PubMed ID: 23911259]. [PubMed Central ID: PMC4196267]. https://doi.org/10.1016/j.schres.2013.07.009.

  • 5.

    Sanchez-Torres AM, Basterra V, Moreno-Izco L, Rosa A, Fananas L, Zarzuela A, et al. Executive functioning in schizophrenia spectrum disorder patients and their unaffected siblings: a ten-year follow-up study. Schizophr Res. 2013;143(2-3):291-6. [PubMed ID: 23265775]. https://doi.org/10.1016/j.schres.2012.11.026.

  • 6.

    Tuulio-Henriksson A. Cognitive dysfunction in schizophrenia: a familial and genetic approach. Publications of the National Public Health Institute; 2005.

  • 7.

    Chen J, Yao Z, Qin J, Yan R, Hua L, Lu Q. Abnormal inter- and intra-hemispheric integration in male paranoid schizophrenia: a graph-theoretical analysis. Shanghai Arch Psychiatry. 2015;27(3):158-66. [PubMed ID: 26300598]. [PubMed Central ID: PMC4526828]. https://doi.org/10.11919/j.issn.1002-0829.215036.

  • 8.

    Goleman D, Baron R, Parker JA. The emotional of intelligence theory development assessment and application at home school and in the workplace. 16. San Joss Bass; 2005. p. 22-9.

  • 9.

    Mohnke S, Erk S, Schnell K, Romanczuk-Seiferth N, Schmierer P, Romund L, et al. Theory of mind network activity is altered in subjects with familial liability for schizophrenia. Soc Cogn Affect Neurosci. 2016;11(2):299-307. [PubMed ID: 26341902]. [PubMed Central ID: PMC4733339]. https://doi.org/10.1093/scan/nsv111.

  • 10.

    Chen X, Zhang ZH, Song Y, Yuan W, Liu ZX, Tang MQ. A paired case-control comparison of ziprasidone on visual sustained attention and visual selective attention in patients with paranoid schizophrenia. Eur Rev Med Pharmacol Sci. 2015;19(16):2952-6. [PubMed ID: 26367712].

  • 11.

    Johnson SL, Tharp JA, Peckham AD, McMaster KJ. Emotion in bipolar I disorder: Implications for functional and symptom outcomes. J Abnorm Psychol. 2016;125(1):40-52. [PubMed ID: 26480234]. [PubMed Central ID: PMC4701591]. https://doi.org/10.1037/abn0000116.

  • 12.

    Marashi F, Nikmanesh Z. The Effectiveness of Emotion Regulation Training with a Positive Thinking Approach in Quality of Life and Its Dimensions Among Children with Cancer. Jundishapur J Chron Dis Care. 2017;7(1). https://doi.org/10.5812/jjcdc.61159.

  • 13.

    Kurtz MM, Gerraty RT. A meta-analytic investigation of neurocognitive deficits in bipolar illness: profile and effects of clinical state. Neuropsychology. 2009;23(5):551-62. [PubMed ID: 19702409]. [PubMed Central ID: PMC2804472]. https://doi.org/10.1037/a0016277.

  • 14.

    American Psychiatric Association. Seyed Mohammadi Y, translator. [Diagnostic and Statistical Manual of Mental Disorders]. 1st ed. Tehran: Ravan Publication; 2014. Persian.

  • 15.

    O'Driscoll C, Laing J, Mason O. Cognitive emotion regulation strategies, alexithymia and dissociation in schizophrenia, a review and meta-analysis. Clin Psychol Rev. 2014;34(6):482-95. [PubMed ID: 25105273]. https://doi.org/10.1016/j.cpr.2014.07.002.

  • 16.

    Strauss GP, Wilbur RC, Warren KR, August SM, Gold JM. Anticipatory vs. consummatory pleasure: what is the nature of hedonic deficits in schizophrenia? Psychiatry Res. 2011;187(1-2):36-41. [PubMed ID: 21295860]. [PubMed Central ID: PMC3070867]. https://doi.org/10.1016/j.psychres.2011.01.012.

  • 17.

    Hong J, Bang M. Anti-inflammatory Strategies for Schizophrenia: A Review of Evidence for Therapeutic Applications and Drug Repurposing. Clin Psychopharmacol Neurosci. 2020;18(1):10-24. [PubMed ID: 31958901]. [PubMed Central ID: PMC7006977]. https://doi.org/10.9758/cpn.2020.18.1.10.

  • 18.

    Kingdon DG, Turkington D. Cognitive-behavioral therapy of schizophrenia. Psychology Press; 2022.

  • 19.

    Jahandar M, Badeleh M, Badeleh MT, Mohamad khani S. The effectiveness of a short cognitive behavioral group intervention on quality of life and illness perception in patients with type 2 diabetes disease. ijdld. 2016;15(6):371-381.

  • 20.

    Godfrin KA, van Heeringen C. The effects of mindfulness-based cognitive therapy on recurrence of depressive episodes, mental health and quality of life: A randomized controlled study. Behav Res Ther. 2010;48(8):738-46. [PubMed ID: 20462570]. https://doi.org/10.1016/j.brat.2010.04.006.

  • 21.

    Driessen E, Hollon SD. Motivational interviewing from a cognitive behavioral perspective. Cogn Behav Pract. 2011. https://doi.org/10.1016/j.cbpra.2010.02.007.

  • 22.

    Kingdon D, Turkington D. Cognitive therapy of psychosis: Research and implementation. Schizophr Res. 2019;203:62-5. [PubMed ID: 29129504]. https://doi.org/10.1016/j.schres.2017.09.023.

  • 23.

    Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database Syst Rev. 2004;(4). CD000524. [PubMed ID: 15495000]. https://doi.org/10.1002/14651858.CD000524.pub2.

  • 24.

    Mohammadi J, Narimani M, Bagyan MJ, Dereke M. [Effects of Cognitive-Behavioral Therapy on Positive Symptoms of Schizophrenia]. Stud Med Sci. 2014;25(3):182-90. Persian.

  • 25.

    Gall M, Borg W, Gall J. Nasr AR, translator. [Quantitative and qualitative research methods in educational sciences and psychology]. Tehran, Iran: Samat Publications; 2017. Persian.

  • 26.

    Kingdon DG, Turkington D. Cognitive therapy of schizophrenia. Guilford Press; 2004.

  • 27.

    Keeler LA. The Differences in Sport Aggression, Life Aggression, and Life Assertion Among Adult Male and Female Collision, Contact, and Non-Contact Sport Athletes. J Sport Behav. 2007;30(1).

  • 28.

    Grossarth-Maticek R, Eysenck HJ. Self-regulation and mortality from cancer, coronary heart disease, and other causes: A prospective study. Pers Individ Differ. 1995;19(6):781-95. https://doi.org/10.1016/s0191-8869(95)00123-9.

  • 29.

    Besharat MA. Psychometri properties of a short version of the self-regulation inventory in a sample of Iranian population. Res Clin Psychol Couns. 2012;1(2). https://doi.org/10.22067/ijap.v1i2.8173.

  • 30.

    Marqués MJ, Ibáñez MI, Ruipérez MA, Moya J, Ortet G. The Self-regulation Inventory (SRI): Psychometric properties of a health related coping measure. Pers Individ Differ. 2005;39(6):1043-54. https://doi.org/10.1016/j.paid.2005.02.030.

  • 31.

    Schmeichel BJ, Zell A. Trait self-control predicts performance on behavioral tests of self-control. J Pers. 2007;75(4):743-55. [PubMed ID: 17576357]. https://doi.org/10.1111/j.1467-6494.2007.00455.x.

  • 32.

    Sobhani M, Moradi, Alibaigi N, Dolatshahi B. [The Efficacy of Cognitive- Behavior Therapy in Reducing Symptoms and Improving Function For Patients with Schizophrenia]. Clin Psychol Stud. 2010;1(1):101-28. Persian.

  • 33.

    Cichy KE, Lefkowitz ES, Fingerman KL. Conflict engagement and conflict disengagement during interactions between adults and their parents. J Gerontol B Psychol Sci Soc Sci. 2013;68(1):31-40. [PubMed ID: 22562969]. [PubMed Central ID: PMC3605941]. https://doi.org/10.1093/geronb/gbs046.

  • 34.

    Hermann C, Ofer J, Flor H. Covariation bias for ambiguous social stimuli in generalized social phobia. J Abnorm Psychol. 2004;113(4):646-53. [PubMed ID: 15535796]. https://doi.org/10.1037/0021-843X.113.4.646.

  • 35.

    Brown KW, Ryan RM. The Benefits of Being Present: Mindfulness and Its Role in Psychological Well-Being. J Pers Soci Psychol. 2003;84:822-48. https://doi.org/10.1037/0022-3514.84.4.822.

  • 36.

    Ghasemzadeh Nasaji S, Peyvastegar M, Hoseinian S, Mutabi F, Banihashem S. [Effectiveness of cognitive-behavioral intervention on coping responses and cognitive emotion regulation strategies]. Int J Behav Sci. 2010;4(1):35-43. Persian.

  • 37.

    Garnefski N, Kraaij V, Spinhoven P. Negative life events, cognitive emotion regulation and emotional problems. Pers Individ Differ. 2001;30(8):1311-27. https://doi.org/10.1016/s0191-8869(00)00113-6.

  • 38.

    Patel A, Knapp M, Romeo R, Reeder C, Matthiasson P, Everitt B, et al. Cognitive remediation therapy in schizophrenia: cost-effectiveness analysis. Schizophr Res. 2010;120(1-3):217-24. [PubMed ID: 20056391]. https://doi.org/10.1016/j.schres.2009.12.003.

  • 39.

    Wykes T, Newton E, Landau S, Rice C, Thompson N, Frangou S. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res. 2007;94(1-3):221-30. [PubMed ID: 17524620]. https://doi.org/10.1016/j.schres.2007.03.030.

  • 40.

    Sheybani H, Mikaeili N, Narimani M. The efficacy of cognitive behavior therapy on emotion regulation and irritability of the students suffered from disruptive mood dysregulation disorder. J Sch Psychol. 2022;11(1):56-67. https://doi.org/10.22098/jsp.2022.1569.